Look who's attending the 13th Annual Immunogenicity for Biotherapeutics Conference

The 13th Annual Immunogenicity for Biotherapeutics conference will be the most scientifically focused, business-critical event in the immunology industry all year – and we’re very much looking forward to welcoming you to all of the event’s learning and networking opportunities. In addition to our three expert presenters from FDA, you definitely will not want to miss our in-depth examinations of proven strategies for epitope minimization and tolerance induction, as well as improving the immune profiling of follow-on biologics.

Who else will be joining us in Baltimore?

* Acceleron Pharma * Adnexus Therapeutics a Bristol Myers Squibb R & D Company * Allergan Inc * Alliance Pharma * Alta Analytical Intertek * Ambrx Inc * Amgen Inc * Amylin Pharmaceuticals * Astellas Pharma Global Development * Bayer Health Care * Biogen Idec Inc * BioMarin Pharmaceuticals * Boehringer Ingelheim * Bristol Myers Squibb * Charles River Laboratories * Childrens Hospital Philadelphia * Cirion * Covance * Duke Medicine * Eli Lilly & Company * EpiVax * F Hoffmann La Roche * Ferring Pharmaceuticals AS * Focus Diagnostics * Food & Drug Administration FDA * Genentech Incorporated * GlaxoSmithKline * Gyros US Inc * Halozyme Therapeutics Inc * Human Genome Sciences Inc * Ipsen Group * Kyowa Hakko Kirin Co Ltd * Lonza Biologics Plc * MedImmune * Menendez Bio-Consulting * Merck & Company * Meso Scale Discovery * Midwest BioResearch * MorphoSys AG * NCI Frederick * PerkinElmer * Perseid Therapeutics * Pfizer * ProImmune * Protalix Biotherapeutics * Puget Sound Blood Center * Quest Diagnostics * Roche Group * Sachem Inc * Scripps Research Institute * Shire Human Genetic Therapies * SUNY University at Buffalo * Teva Biopharmaceuticals USA Inc * The Jackson Laboratory * University of British Columbia Genetics & Health Research Cluster * University of Massachusetts Medical School * University of Rhode Island * Viracor IBT Laboratories * ZymoGenetics Inc *

For more information on this year’s program, visit the webpage.

The Immunogenicity for Biotherapeutics Conference is taking place April 17-19, 2012.  If you have any questions about the agenda, feel free to contact Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |